UK Department for International Trade United Kingdom

A number of companies shown here with profiles and logos are financially supported by the UK government's Tradeshow Access Programme.

Accunea

Accunea is led by a rounded group of clinicians, scientists, and experts in translational research and development

Website:
www.accunea.com
Keywords
Dr Nick Housby
CEO 

Almac Group

The Almac Group is an established contract development and manufacturing organisation that provides an extensive range of integrated services to the pharmaceutical and biotech sectors globally.

Keywords
Organisation type
Mr Simon Hamilton
Business Development Manager 
Mrs Ruth Fowler
Marketing Associate 

ApconiX Ltd

ApconiX are experts in ion channel biology, target safety assessments and in all aspects of nonclinical programme design and delivery.

ApconiX was formed by three AstraZeneca colleagues with the drive and ambition to create a world-renowned company founded on the skills and experience of a growing team with a wide range of expertise in nonclinical drug safety.

The model for the pharmaceutical industry has evolved in recent years with large pharma reducing internal capability and outsourcing key skills to trusted partners.  There are many more SMEs and academic groups who also need access to specialised services.

ApconiX addresses all needs by providing an exceptional group of scientists to these companies, in a cost-effective and flexible way.  In this way, companies work with people they trust, to make better decisions on drug safety.

  

Website:
www.apconix.com
Organisation type
Dr Richard Knight
Director 

Arcinova

Arcinova is a UK based Contract Research and Development Organisation (CRDO) operating from a 15,000m2 site which has benefited from more than 36 years of investment as a key research and development centre. We provide the pharmaceutical industry with a comprehensive range of services, backed by extensive scientific expertise and strong practical capabilities.

We work to enhance the health and wellbeing of society by helping companies to develop life changing medicines and take them to market quickly, effectively and efficiently.

Our focus is on API process research, the development, validation and application of analytical, microbiological and materials science spectroscopic methodologies, scale-up and early phase clinical product manufacturing. We provide non-clinical and clinical 14C, API, drug product, bioanalysis, regulatory and consulting services.

Our mission at Arcinova is to delight our life sciences customers by satisfying their contract research, development and manufacturing needs with agility, innovation, seamless teamwork and best value delivery.

   

Website:
www.arcinova.com
Keywords
Organisation type
Dr Nathalie Huther
Senior Director Business Development, Europe 

BioPartner UK

BioPartner UK leads the UK Delegation to several partnering conferences
each year. It is a UK Accredited Trade Organisation facilitating international partnering for trade, investment and collaborations with Life Sciences organisations across the UK. BioPartner is a membership organisation, supporting UK SMEs and startups, and signposting organisations worldwide to UK expertise.

BioPartner has alliances with organisers of international biopartnering events, and with UK membership organisations, operating both independently and
in partnership with the UK government. BioPartner disseminates tradeshow access grants to help UK-based SMEs exhibit their services and products in new overseas markets. 

   

Ms Lin Bateson
Chief Executive 
Dr Alasdair Stamps
Chairman 
Miss Paula Paton
Administrator 
Mrs Della Bateson
Finance 

Cambridge Cancer Genomics

Website:
www.ccg.ai
Dr Nirmesh Patel
Co-Founder & CSO 

CEIDR

Website:
www.ceidr.org.uk
Keywords
Organisation type
Dr Lisa Baldwin
Business Development Manager 
Dr Becky Jones-Phillips
Business Development Manager 

Drug Discovery & Development Consultants Ltd

Keywords
Organisation type
Dr Isabel Gonzalez
Director 

IAG Ltd

IA-Group is a strategic partner to bio-pharmacutical companies. We bring extensive therapeutic knowledge and regulatory expertise in strategic use of clinical imaging to enhance understanding of the mode of action, to increase the efficiency of clinical decisions and to accelerate drug development.

IA’s operations team leverage our global footprint and the next-generation cloud based proprietry platform Dynamika to de-risk trial execution and to ensure data quality and integrity. Our venture arm pioneer unique targeted investment and risk-sharing models to enable our clients to reach the next value inflection point faster. We fuse decades of theraputic insight and agile culture to meet today's speed and high standard of therapeutic innovation.

   

Website:
www.ia-grp.com
Keywords
Organisation type
Dr Diana Roettger
Bio-Partnering Director